Nightingale Health & UK Biobank announce major initiative to analyze

(Nightingale Health) Nightingale Health, the Finnish innovator of an internationally recognized blood biomarker technology for studying chronic diseases, will analyze the biomarker profiles of 500,000 blood samples from UK Biobank. The ground-breaking research initiative was announced today at the UK Biobank Scientific Conference 2018 in London.

Nightingale Health & UK Biobank announce major initiative to analyze 500,000 blood samples

Related Posts

Agriculture accelerated human genome evolution to capture energy from starchy foods

Samples from bottled water, tap water and household-treated tap water in San Francisco Bay Area indicate that all sources may have potential health risks, largely from trihalomethanes

Both cats and dogs often enjoy playing fetch with their owners

PCORI offers up to $100 million for new research promoting healthy children and youth

POPULAR NEWS

NYU Abu Dhabi researchers identify unique survival strategies adopted by fish in the world’s warmest waters

CHOP experts describe types of rashes associated with MIS-C

Scientists discover that a protein associated with neurodegenerative diseases is also linked to childhood brain cancer

Automatic design of metaheuristics: The future of optimization?

About

Follow us

Recent News

A new, updated account of poroid fungi in North America

Few anti-immigration users dominate most of UK-based anti-immigration content on Twitter with rapid spread and high polarization

Agriculture accelerated human genome evolution to capture energy from starchy foods

Welcome Back!

Retrieve your password